Meeting
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Low molecular weight heparin (LMWH) enhances immunotherapy (I) activity in pancreatic cancer cells.
Authors
Michalis Karamouzis
National and Kapodistrian University of Athens, Athens, Greece
Michalis Karamouzis, Alexandros Bokas, Georgia Kyriakopoulou, Evangelos Koustas, Panagiotis Sarantis, Pavlos Papakotoulas, Dimitrios Schizas, Alexandros Papalampros, Evangelos Felekouras, Theodoros Liakakos, Athanasios G. Papavassiliou
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies
Sub Track
Immune Checkpoints and Stimulatory Receptors
Citation
J Clin Oncol 37, 2019 (suppl 8; abstr 50)
DOI
10.1200/JCO.2019.37.8_suppl.50
Abstract #
50
Poster Bd #
C4
Abstract Disclosures